Docmode Health

Why is Docmode Health Technologies Ltd falling/rising?

As of 02-Sep, the stock price of Docmode Health Technologies Ltd is at 32.60, unchanged from the previous session. The stock has seen a significant decline of 54.28% year-to-date, indicating a bearish trend despite increased investor participation.

As of 02-Sep, the stock price of Docmode Health Technologies Ltd is currently at 32.60, showing no change from the previous trading session. Over the past week, the stock has declined by 1.21%, and it has experienced a more significant drop of 8.56% over the past month. Year-to-date, the stock has fallen by 54.28%, which is considerably worse than the Sensex's decline of 8.48% during the same period. <BR><BR>Despite the current price remaining stable, the stock's performance indicates a downward trend over longer periods, with a 24.27% decrease over the past year. The moving averages suggest that while the stock is performing better than its 5-day and 20-day averages, it remains below the 50-day, 100-day, and 200-day moving averages, indicating a longer-term bearish trend.<BR><BR>However, there is a notable increase in investor participation, with delivery volume rising by 172.73% against the 5-day average, which could suggest growing interest or confidence among investors. Nevertheless, the overall performance metrics indicate that the stock is currently in a declining phase, primarily driven by its significant losses over the year and month.

Which are the latest news on Docmode Health?

Who are the peers of the Docmode Health?

Docmode Health's peers include Maitreya Medica, Sangani Hospital, Aatmaj Health, and others, with varying management risks and growth rates. Sangani Hospital leads in 1-year returns at -21.52%, while Maitreya Medica has the lowest at -53.58%.

Peers: The peers of Docmode Health are Maitreya Medica., Sangani Hospital, Aatmaj Health, Nidan Laborator., Broach Lifecare, Global Longlife, KK Shah Hospital, Soni Medicare, Shanmuga Hos., and Fortis Malar.<BR><BR>Quality Snapshot: Below Average management risk is observed at Maitreya Medica., Sangani Hospital, Nidan Laborator., Docmode Health, Broach Lifecare, KK Shah Hospital, Soni Medicare, and Fortis Malar, while Average management risk is found at Aatmaj Health and Global Longlife, and Excellent management risk is noted at Shanmuga Hos. Growth is Excellent at Sangani Hospital, Average at Aatmaj Health and Global Longlife, and Below Average at the rest. Capital Structure is Good at Sangani Hospital, Aatmaj Health, Broach Lifecare, and KK Shah Hospital, while Below Average is seen at the remaining peers.<BR><BR>Return Snapshot: Sangani Hospital has the highest 1-year return at -21.52%, while Maitreya Medica. has the lowest at -53.58%, with Docmode Health's 1-year return being N/A. Additionally, Nidan Laborator., Docmode Health, and Maitreya Medica. have negative six-month returns.

What does Docmode Health do?

Docmode Health Technologies Ltd is a micro-cap healthcare technology company focused on enhancing medical education, research, and practice in hospitals. It became a public limited company in January 2023, with a market cap of INR 10 Cr, but lacks recent revenue and profit data.

Overview:<BR>Docmode Health Technologies Ltd is a pioneering healthcare technology company that transforms medical education, research, and practice within the hospital industry, categorized as a micro-cap company.<BR><BR>History:<BR>Docmode Health Technologies Limited was incorporated on July 17, 2017, as a private limited company and was converted into a public limited company effective January 2, 2023. Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 10 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: N/A<BR>Industry P/E: 160<BR>Dividend Yield: 0.00%<BR>Debt-Equity: 0.59<BR>Return on Equity: -24.30%<BR>Price-to-Book: 1.25<BR><BR>Contact Details:<BR>Registrar Address: Not available.

How big is Docmode Health?

As of 10th June, Docmode Health Technologies Ltd has a market capitalization of 14.00 Cr, classifying it as a Micro Cap company, with no available financial data for Net Sales or Net Profit for the latest four quarters. The balance sheet as of March 2025 shows Shareholder's Funds of 8.35 Cr and Total Assets of 39.06 Cr.

As of 10th June, <BR><BR>Market Cap: Docmode Health Technologies Ltd has a market capitalization of 14.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 8.35 Cr and Total Assets valued at 39.06 Cr.

How has been the historical performance of Docmode Health?

Docmode Health has experienced significant sales growth from 12.42 Cr in March 2022 to 41.77 Cr in March 2025, but rising expenditures have led to negative operating profit and losses in profit before and after tax, with EPS dropping to -6.46. Total assets and liabilities have increased to 39.06 Cr by March 2025, while cash flow remains tight.

Answer:<BR>The historical performance of Docmode Health shows a fluctuating trend in key financial metrics over the past four fiscal years.<BR><BR>Breakdown:<BR>Docmode Health's net sales have increased from 12.42 Cr in March 2022 to 41.77 Cr in March 2025, indicating a strong growth trajectory. However, the total expenditure has also risen significantly, from 10.54 Cr in March 2022 to 42.45 Cr in March 2025, leading to an operating profit (PBDIT) that turned negative at -0.68 Cr in March 2025, down from a positive 3.75 Cr in March 2023. Consequently, the profit before tax has declined sharply to -1.97 Cr in March 2025, compared to 2.69 Cr in March 2023. The profit after tax mirrored this decline, falling to -2.03 Cr in March 2025 from 1.95 Cr in March 2023. The company's earnings per share (EPS) also reflect this downturn, dropping to -6.46 in March 2025 from 8.52 in March 2023. On the balance sheet, total assets have increased from 10.01 Cr in March 2022 to 39.06 Cr in March 2025, while total liabilities have also risen from 10.01 Cr to 39.06 Cr in the same period. Cash flow from operating activities improved to 4.00 Cr in March 2024, but the overall cash flow situation remains tight with a closing cash equivalent of 3.00 Cr in March 2024.

Who are the top shareholders of the Docmode Health?

The top shareholders of Docmode Health include Paulson Paul Thazhathedath, who holds 23.71%, and individual investors who collectively own 48.97%. There are no mutual funds or foreign institutional investors involved, and pledged promoter holdings are at 61.1641%.

The top shareholders of Docmode Health primarily consist of non-institutional investors. The promoter with the highest holding is Paulson Paul Thazhathedath, who owns 23.71% of the company. Additionally, individual investors collectively hold 48.97% of the shares. There are no mutual funds or foreign institutional investors currently holding shares in the company. The pledged promoter holdings stand at 61.1641%.

Is Docmode Health overvalued or undervalued?

As of June 2, 2025, Docmode Health is classified as risky and overvalued, with a PE ratio of -10.42 and a year-to-date return of -23.83%, significantly underperforming compared to its peers and the Sensex.

As of 2 June 2025, the valuation grade for Docmode Health has moved from does not qualify to risky. The company is currently assessed as overvalued. Key ratios indicate significant financial distress, with a PE ratio of -10.42, an EV to EBIT of -27.08, and a ROE of -19.55%. <BR><BR>In comparison to its peers, Docmode Health's valuation metrics are starkly unfavorable; for instance, Veranda Learning, also classified as risky, has a PE ratio of 165.27, while Shanti Educational Initiatives Ltd. is deemed very expensive with a PE ratio of 199.65. The recent stock performance shows a significant decline, with a year-to-date return of -23.83%, contrasting sharply with the Sensex's gain of 6.24% during the same period, further reinforcing the overvaluation narrative.

What is the technical trend for Docmode Health?

As of June 2, 2025, Docmode Health's trend has shifted to mildly bearish due to daily moving averages indicating bearish momentum, despite some underlying strength from weekly MACD and a neutral outlook from Dow Theory.

As of 2 June 2025, the technical trend for Docmode Health has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, primarily driven by the daily moving averages indicating bearish momentum. The weekly MACD remains mildly bullish, suggesting some underlying strength, but the overall trend is tempered by the daily indicators. The RSI shows no signal across both weekly and monthly time frames, indicating a lack of momentum. Additionally, the Dow Theory shows no trend in both weekly and monthly perspectives, further supporting a neutral outlook. Overall, while there are some bullish signals in the weekly indicators, the prevailing daily bearish trend suggests caution.

When is the next results date for Docmode Health?

No Upcoming Board Meetings

Has Docmode Health declared dividend?

No Dividend History Available